Blood Res 2016; 51(4): 297-299  https://doi.org/10.5045/br.2016.51.4.297
Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab
Chul Won Jung1, Su-Hee Cho2, Sylvia Park1, Jun Ho Jang1, Jun Ho Ji3
1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 2Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, 3Division of Hematology-Oncology, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University of School of Medicine, Seoul, Korea
Correspondence to: Chul Won Jung
Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-ro, Gangnam-gu, Seoul 06351, Korea
E-mail: leukemia1@skku.edu
Received: June 1, 2016; Revised: June 29, 2016; Accepted: September 22, 2016; Published online: December 31, 2016.
© The Korean Journal of Hematology. All rights reserved.

cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Current Issue

ba_link01

Indexed/Covered by